Bioadaptor meets expectations in reducing target lesion failures in coronary artery disease Presented ByProf. David Erlinge, Lund University, Sweden TrialINFINITY-SWEDEHEART ConferenceESC 2024 TypePeer-reviewed article 7 November 2024 12:48